newsfilter
← Latest News
GlobeNewswire·

TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director

  • TELA Bio, Inc. has appointed Heather Getz as Chief Executive Officer & Director, effective August 04, 2026.
  • Getz previously served as Executive Vice President & Chief Financial & Operations Officer at Butterfly Network, Inc.
  • Prior to Butterfly, Getz was Executive Vice President & Chief Financial & Administrative Officer at BioTelemetry, Inc., where market capitalization grew from $50 million to $2.8 billion before its 2021 acquisition by Philips Healthcare.
  • Antony Koblish, Co-Founder of TELA Bio, is stepping down from leadership after founding the company & developing the OviTex™ product.
  • Joseph Capper, Chairman of the Board, cited Getz's track record in operational excellence & complex business transformations as key reasons for her appointment.
  • Getz aims to accelerate commercial execution, strengthen customer relationships, & expand the impact of TELA Bio's soft-tissue reconstruction solutions.
  • TELA Bio is a commercial-stage medical technology company focused on optimizing clinical outcomes through the preservation & restoration of patient anatomy.
  • The press release includes standard forward-looking statements regarding risks such as leadership transitions, macroeconomic conditions, & product market acceptance.